Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 38

Session: Subspecialty Networking Breakout: NEC

Subspecialty Networking Breakout: NEC

Sunday, May 5, 2024
10:00 AM – 10:50 AM ET
Location: Metro Toronto Convention Centre: 714

    Facilitator(s)

  • Jennifer M. Canvasser, MSW (she/her/hers)

    Founder, Executive Director
    NEC Society
    Davis, California, United States

  • Ravi M. Patel, MD, MSc (he/him/his)

    Professor of Pediatrics
    Emory University & Children's Healthcare of Atlanta
    Atlanta, Georgia, United States

  • Misty Good, MD, MS (she/her/hers)

    Division Chief
    University of North Carolina at Chapel Hill School of Medicine
    Chapel Hill, North Carolina, United States

  • Camilia Martin, MD. MS (she/her/hers)

    Professor of Pediatrics
    Weill Cornell Medicine
    New York, New York, United States

Disclosure(s):
Jennifer M. Canvasser, MSW: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ravi M. Patel, MD, MSc: Infant Bacterial Therapeutics / Premier Research (Ongoing) (Products/Services: Consultant); Noveome (Ongoing) (Products/Services: Consultant)
Misty Good, MD, MS: Evive Biotech, Inc. (Terminated, July 1, 2023) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Camilia Martin, MD. MS: Baxter (Ongoing) (Products/Services: Consultant); Lactalogics (Ongoing) (Products/Services: Advisory Committee); Mead Johnson/Reckitt (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Plakous Therapeutics (Ongoing) (Products/Services: Advisory Committee); Vitara Biomedical (Ongoing) (Products/Services: Advisory Committee)